J Kuhn1, C Noda2, G V Massey1. Show Affiliations » 1. Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA. 2. Department of Pharmacy, Virginia Commonwealth University Health System, Richmond, VA, USA.
Abstract
Entities: Disease
Mesh： See more » Anaphylaxis/prevention & controlAntibodies, Blocking/metabolismChildCombined Modality TherapyDesensitization, Immunologic/methodsDiphenhydramine/therapeutic useDrug Hypersensitivity/immunologyDrug Hypersensitivity/therapyEpinephrine/administration & dosageFactor IX/immunologyFactor VIIa/therapeutic useHemophilia B/immunologyHemophilia B/therapyHumansImmune ToleranceIsoantibodies/metabolismMaleRecombinant Proteins/immunologyRespiratory SoundsRituximab/therapeutic useVomiting
Substances： See more » Antibodies, BlockingIsoantibodiesRecombinant ProteinsRituximabMononineDiphenhydramineFactor IXFactor VIIaEpinephrine
Year: 2018 PMID： 29600592 DOI： 10.1111/hae.13457
Source DB: PubMed Journal: Haemophilia ISSN： 1351-8216 Impact factor: 4.287